Larson Yi 4
4 · LianBio · Filed Nov 1, 2021
Insider Transaction Report
Form 4
LianBioLIAN
Larson Yi
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-10-31+229,538→ 1,196,845 totalExercise: $16.00Exp: 2031-10-31→ Ordinary Shares (229,538 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option shall vest and become exercisable on October 31, 2022; the remainder shall vest and become exercisable in three equal annual installments such that the option shall be fully vested on October 31, 2025, subject to the Reporting Person providing continuous service to the Issuer on each such date.